Jialing Xiao

机构：University of Electronic Science and Technology of China, Chinese Academy of Medical Sciences & Peking Union Medical College, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital · ORCID：0000-0002-4081-5525

发表论文 27 篇 · 总被引 175 次 · h-index 8

代表论文

• A genetic variant in IL-6 lowering its expression is protective for critical patients with COVID-19 (2022 · Signal Transduction and Targeted Therapy · 被引 29)
• <p>Oral Prevalence of <em>Candida</em> Species in Patients Undergoing Systemic Glucocorticoid Therapy and the Antifungal Sensitivity of the Isolates</p> (2020 · Infection and Drug Resistance · 被引 20)
• Revised International Staging System (R-ISS) stage-dependent analysis uncovers oncogenes and potential immunotherapeutic targets in multiple myeloma (MM) (2022 · eLife · 被引 19)
• Quick Treatment of Very Severe Refractory Hand and Foot Eczema with Dupilumab: A Case Report and Literature Review (2023 · Journal of Asthma and Allergy · 被引 15)
• Diagnostic serum biomarkers associated with ankylosing spondylitis (2022 · Clinical and Experimental Medicine · 被引 12)
• Pannexin 3 activates P2X7 receptor to mediate inflammation and cartilage matrix degradation in temporomandibular joint osteoarthritis (2023 · Cell Biology International · 被引 11)